Newsroom
Our latest developments
Orca Bio’s announcements and press releases
Orca Bio Appoints Bijan Nejadnik, M.D., as Chief Medical Officer
ViewOrca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies
ViewOrca Bio Announces FDA Review Extension of BLA for Orca-T for the Treatment of Hematologic Malignancies
ViewOrca Bio to Present Clinical Data on Its Pipeline of High-Precision Cell Therapies at the 52nd Annual Meeting of the EBMT
ViewOrca Bio Presents New Data at the 2026 Tandem Meetings of ASTCT® and CIBMTR® Reinforcing Orca-T® as a Durable, High-Precision Cell Therapy for Hematological Malignancies
ViewOrca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
ViewOrca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
ViewOrca Bio's fact sheets
Orca Bio Corporate Overview
View